Inhibitex, Inc.
Acquired By: Bristol-Meyers

Biopharmaceutical company focused on novel antibody-based products for serious hospital-associated bacterial and fungal infections

Sector: Biopharmaceuticals, Healthcare
Company Status: Public/Acquired
Investment Status: Historical